Photos, Videos & Infographics

Innovation

August 25, 2017

A Closer Look at Coronary Artery Disease and Peripheral Artery Disease

Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) affect 16.5 million and 10 million Americans, respectively. Learn more about CAD and PAD and whether you could be at risk.

ON NOW

Media Center

October 14, 2016

10 Working Moms Share What It Means to Be a Mother at Johnson & Johnson

We’re proud to be named to the Best Companies for Working Moms list by Working Mother magazine. But why were we? Hear the real scoop from 10 Johnson & Johnson working moms!

ON NOW

10 Working Moms Share What It Means to Be a Mother at Johnson & Johnson

Health & Wellness

December 01, 2015

The Lake Nona Life Project

ON NOW

Health & Wellness

December 01, 2015

Supporting World Inflammatory Bowel Disease Day

ON NOW

Health & Wellness

December 01, 2015

Supporting World Autoimmune Arthritis Day

ON NOW

Health & Wellness

December 01, 2015

Johnson's So Much More Global Survey

ON NOW

Health & Wellness

December 01, 2015

Johnson's Science of the Senses

ON NOW

Health & Wellness

December 01, 2015

Johnson's The Power of Bath Time

ON NOW

Health & Wellness

December 01, 2015

It's Time to Act on Obesity

ON NOW

Health & Wellness

December 01, 2015

Tuberculosis & Multi-Drug Resistant Tuberculosis

ON NOW

Health & Wellness

December 01, 2015

Blood Clot and Cancer Connection

ON NOW

Health & Wellness

October 01, 2015

Early Intervention in Schizophrenia

ON NOW

More From J&J

Innovation

The COVID-19 Data Plan: 3 Innovative Ways Johnson & Johnson Is Using Data Science to Fight the Pandemic

Tracking the spread of the virus in real time. Analyzing data to learn more about who's most vulnerable. These are just a couple of ways the company's data science team is helping inform how to respond to the pandemic.

ON NOW

Innovation

COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate Answered

With its Phase 3 clinical trial now fully enrolled, the Global Head of Research & Development at Janssen brings us up to speed on the progress of the company's vaccine candidate, including upcoming key milestones.

ON NOW

Photos, Videos & Infographics

Section

Type

More From J&J